Using quantitative RT-PCR techniques, high sensitivity and precision are crucial for correct detection of low transcript levels, for example, in the evaluation of minimal residual disease (MRD). From a primary view, the greater number of PCR cycles in a nested competitive PCR assay may provide improved sensitivity of this approach when compared to real-time RT-PCR like Taqman (usually 65-75 vs 40 cycles). The very interesting results of Guo et al 1 support this impression and clearly underscore the clinical importance of a carefully designed RT-PCR method for the detection of low transcript levels.
However, it remains open as to which of the two approaches may provide a superior level of validity, reliability, and freedom from bias. For instance, patient 6 from 9/12/01 was scored negative in Taqman PCR, while nested competitive PCR measured 0.1 transcripts per microgram RNA. In all, 1-5 mg was subjected to cDNA synthesis in a total volume of 40 ml, and 2.5 ml cDNA was subsequently used in the PCR. Consequently, a single PCR tube contained 0.3125 mg RNA equivalent at the most. Thus, the tube would have contained 0.03125 transcripts, a rather questionable finding.
In addition, from a mathematical point of view, we would like to comment on the influence of stochastics, which significantly contributes to the accuracy of transcript quantification at low transcript levels. Since RNA molecules are distinct entities, their quantification has to consider the Poisson type of distribution, which is named after the French mathematician Siméon Denis Poisson (1781-1840) and is a borderline case of the binominal distribution for rare events. In the case of RNA quantification, the Poisson distribution predicts the frequency distribution of the number of RNA molecules that will be present for measurement in each PCR tube of a patient's sample. In this context, stochastic fluctuations influence sensitivity as well as precision of quantification when only a small amount of quantifiable transcripts is available, for example, under the conditions of MRD. If, for example, a PCR reaction is expected to contain a single molecule of target RNA, Poisson distribution predicts probabilities of 36.8, 36.8, 18.4, 6.1, 1.5, 0.3, and 0.1% for 0, 1, 2, 3, 4, 5, and 6 molecules, respectively, to be actually present in the PCR tube. Two practical points can be derived from this theoretical background that may potentially compromise the results of Guo et al 1 . At first, the number of measurement repetitions becomes highly important in the detection of rare transcripts and significant differences of gene transcription. Sample size can be calculated approximately from the standardized difference d ¼ [expected value mÀreference value m 0 ]/Ovariance s 2 , with s 2 ¼ expected value in the case of Poisson distribution. Providing a type I error of a ¼ 0.05 and a power of 80%, a sample size of at least 19, 7, and 3 repeats is required to differentiate between 2 and 1 copies, 4 and 1 copies, and 10 and 1 copies, respectively. 2 Second, repeated measurements of a given sample with low transcript numbers should exactly reflect the Poisson type of distribution. In this work, we systematically examined the detection of distinct very low copy numbers using a plasmid vector. All experiments were performed in eight replications. The plasmid contained a 2000 bp insert that was derived from a genomic DNA rearrangement within the MLL gene. This genomic MLL rearrangement was previously cloned from an infant with translocation t(11;19). The linearized and dephosphorylated plasmid was diluted in a large volume of 1 ml in 50 mg/ml Escherichia coli t-RNA (Roche, Mannheim, Germany) to obtain concentrations ranging from 1 to 8 copies per PCR tube. Primers and probe were as follows:
0 (probe). In all, 40 cycles of Taqman PCR were performed with standard conditions using the manufacturer's recommendations. Primer, probes, and the plasmid standard can be obtained from AB upon request. A standard curve was separately generated using eight-fold replicates of 1:2 dilution steps with 50 mg/ml E. coli t-RNA in the range between 2 0 and 2 11 copies per well. For each step between 1 and 8 copies per tube, the expected values were within the 95% confidence interval of the replicated measurements. 3 In none of the four series, there was statistical difference between the expected values and the observed means (w 2 -test). 4 The index of dispersion R(t), which approximates 1 in the case of Poisson distribution, was in the acceptable range between 0.94 and 3.11 with an average value of 1.44 (Table 1) . 5, 6 These data clearly demonstrate that, considering the properties of the Poisson distribution, Taqman real-time RT-PCR is sensitive enough to detect 1 copy per sample. In addition, its precision allows to exactly quantify even very low copy numbers when RT-PCR conditions are optimized. Our experimental data and their mathematical modelling show that the sensitivity of real-time PCR reaches the limits that are given by stochastics. 
TO THE EDITOR
The studies described in our paper 1 focused on the comparison of two methods of quantitative PCR that are used to estimate levels of BCR-ABL transcripts in minimal residual disease patients with chronic myelogenous leukemia (CML). This investigation was prompted by our observation that levels of BCR-ABL transcripts were routinely underestimated by the realtime PCR method compared to the competitive PCR method. In addition, we observed that the competitive PCR method was more sensitive than the real-time method.
The correspondence by Rawer et al 2 raised important issues. First, they agreed with our findings concerning the increased sensitivity of the competitive method compared to real-time method, stating that 'the greater number of PCR cycles in a nested competitive PCR assay may provide improved sensitivity of this approach when compared to real-time like Taqman (usually 65-75 vs 40 cycles)'. Secondly, they raised doubts about our finding with one of the samples, which showed 0.1 transcripts per microgram of total RNA. Unfortunately, we found that an error was made in setting the galley proof on this data point (no others errors were detected). The original data in our manuscript listed this value as 10 transcripts per microgram of total RNA and not 0.1 transcripts (100-fold difference). This is an unfortunate error, which we failed to uncover in the galley proof. Thus, the arguments put forward by Rawer et al on this result are rendered less important by this error. Using the calculations of Rawer et al, we estimate that the assay tube would contain 3.125 transcripts of BCR-ABL and not 0.03125 transcripts.
The third point requires serious discussion. It concerned samples that scored negative in our assays. Rawer et al are correct in suggesting that the Poisson distribution concept is operative. The number of measurement repetitions is relevant in the detection of rare transcripts. Table 1 shows the probability of observing at least one positive score with number of repetitions from 1 to 8 under the Poisson assumption. For example, with three replicates (which is the number of RT-PCR assays conducted for the Guo et al 1 study), there is a 95% chance to detect at least one positive score when the expected value is 1. Eight replicates would pick up the remaining 5%, but it is not clear that this improvement in sensitivity is worth the cost.
As a practical matter, it is unrealistic to perform sufficient replicate assays to determine whether a given sample is in fact negative or positive with a relatively low value. It is too costly and too time consuming for a clinical lab operation in which many samples must be assayed. Moreover, as discussed in the Discussion section of our paper, 1 the value of a single quantitative PCR data point is less important than the trend of values over a period of time. In our experience, some CML patients have detectable transcripts at very low levels, but their transcript numbers do not increase significantly during long periods of follow-up. Investigators in the field consider the trend of the quantitative PCR results is one of the critical issues. 3 This 'trend' point of view stems from the fact that: (1) PCR assays have an intrinsic variability and thus determining the precise transcript number will require replicate assays (Poisson distribution considerations) and (2) more importantly, any single assay result depends on several factors. These include the variability of RNA degradation in a given sample preparation, the efficiency In Poisson distribution, the variance of numbers ought to equal the mean of numbers. The index of dispersion, R(t), as the ratio of the variance to the mean, should be close to 1. The approximation of R(t) to 1 may serve as a marker to demonstrate the existence of the Poisson distribution of the replicates on each distinct copy step. 5, 6 
